XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Common Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Balance, beginning of period at Dec. 31, 2022   $ 176 $ (930,643) $ 1,519,641 $ 3,786,952 $ (456,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under incentive and benefit plans   2   2,857    
Shares repurchased under share repurchase program (Note 14)   (1)   (20,008)    
Repurchases of common stock under incentive plans     (14,389)      
Share-based compensation       20,405    
Net income $ 303,844       303,844  
Dividends and dividend equivalents declared         (74,314)  
Net unrealized gains (losses) on investments, net of tax 32,934         32,934
Other adjustments to other comprehensive income (loss)           179
Balance, end of period at Jun. 30, 2023 4,170,836 177 (945,032) 1,522,895 4,016,482 (423,686)
Balance, beginning of period at Mar. 31, 2023   176 (931,313) 1,515,852 3,908,396 (386,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under incentive and benefit plans   1   752    
Shares repurchased under share repurchase program (Note 14)   0   (4,852)    
Repurchases of common stock under incentive plans     (13,719)      
Share-based compensation       11,143    
Net income 146,087       146,087  
Dividends and dividend equivalents declared         (38,001)  
Net unrealized gains (losses) on investments, net of tax (37,053)         (37,053)
Other adjustments to other comprehensive income (loss)           0
Balance, end of period at Jun. 30, 2023 4,170,836 177 (945,032) 1,522,895 4,016,482 (423,686)
Balance, beginning of period at Dec. 31, 2023 4,397,805 173 (945,870) 1,430,594 4,243,759 (330,851)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under incentive and benefit plans   2   2,387    
Shares repurchased under share repurchase program (Note 14)   (3)   (100,680)    
Repurchases of common stock under incentive plans     (21,348)      
Share-based compensation       24,040    
Net income 304,257       304,257  
Dividends and dividend equivalents declared         (77,681)  
Net unrealized gains (losses) on investments, net of tax (46,392)         (46,392)
Other adjustments to other comprehensive income (loss)           (68)
Balance, end of period at Jun. 30, 2024 4,482,319 172 (967,218) 1,356,341 4,470,335 (377,311)
Balance, beginning of period at Mar. 31, 2024   171 (946,202) 1,390,436 4,357,823 (362,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under incentive and benefit plans   2   856    
Shares repurchased under share repurchase program (Note 14)   (1)   (50,179)    
Repurchases of common stock under incentive plans     (21,016)      
Share-based compensation       15,228    
Net income 151,903       151,903  
Dividends and dividend equivalents declared         (39,391)  
Net unrealized gains (losses) on investments, net of tax (14,815)         (14,815)
Other adjustments to other comprehensive income (loss)           0
Balance, end of period at Jun. 30, 2024 $ 4,482,319 $ 172 $ (967,218) $ 1,356,341 $ 4,470,335 $ (377,311)